SCHEMBL30178097

SCHEMBL30178097

Cc1cccc2nc(C(=O)N(C)C)cn12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.61
RAB9A P51151 6/20 0.46
NPC1 O15118 3/20 0.46
TP53 P04637 1/20 0.42
MAPT P10636 5/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
KDM4E B2RXH2 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
LMNA P02545 1/20 0.39
RECQL P46063 1/20 0.39
BLM P54132 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TGFBR1 P36897 1/20 0.37
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
BRD4 O60885 1/20 0.36
NAMPT P43490 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2086819 0.85 GAA (0.59) GAARAB9ANPC1TP53MAPT
SCHEMBL10242648 0.82 GAA (0.66) GAARAB9ANPC1TP53MAPT
SCHEMBL119926 0.82 GAA (0.66) GAARAB9ANPC1TP53MAPT
SCHEMBL3282406 0.81 GAA (0.64) GAARAB9ANPC1TP53MAPT
SCHEMBL31295474 0.77 GAA (0.63) GAARAB9ANPC1TP53MAPT
SCHEMBL4243991 0.77 GAA (0.59) GAARAB9ANPC1TP53
SCHEMBL101291 0.76 GAA (1.00) GAARAB9ANPC1MAPTSMN1; SMN2
SCHEMBL23030192 0.75 ALDH1A1 (0.40) GAARAB9ATP53SMN1; SMN2KDM4E
SCHEMBL4212957 0.74 GAA (0.56) GAARAB9ANPC1TP53MAPT
SCHEMBL3367434 0.74 RAB9A (0.65) GAARAB9ANPC1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583870-B2 Azaheteroaryl compound and application thereof SHANGHAI BLUERAY BIOPHARMA CO., LTD. (CN) 2026-03-24 US disclosed
US-20230002414-A1 AZAHETEROARYL COMPOUND AND APPLICATION THEREOF SHANGHAI BLUERAY BIOPHARMA CO., LTD. (CN) 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002414-A1 AZAHETEROARYL COMPOUND AND APPLICATION THEREOF EZH2, EED, SUZ12 GAA 2763/4885RAB9A 531/4885NPC1 1194/4885
US-12583870-B2 Azaheteroaryl compound and application thereof NR3C1, EED, EZH2 GAA 4006/4885RAB9A 467/4885NPC1 558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.